Download presentation
Presentation is loading. Please wait.
Published byOliver Henry Modified over 6 years ago
1
Malaria prevention recommendations for risk groups visiting sub-Saharan Africa: A survey of European expert opinion and international recommendations Mithula Shellvarajah, Christoph Hatz, Patricia Schlagenhauf Travel Medicine and Infectious Disease DOI: /j.tmaid Copyright © 2017 Elsevier Ltd Terms and Conditions
2
Fig. 1 Recommendation for a pregnant VFR (1st trimester) visiting her family in rural Nigeria. P = Atovaquone/proguanil; D = Doxycycline; M = Mefloquine; None. Travel Medicine and Infectious Disease DOI: ( /j.tmaid ) Copyright © 2017 Elsevier Ltd Terms and Conditions
3
Fig. 2 Recommendation for a baby (8 kg) visiting malaria-endemic areas of Sub-Saharan Africa for two weeks. P = Atovaquone/proguanil; D = Doxycycline; M = Mefloquine; None. Travel Medicine and Infectious Disease DOI: ( /j.tmaid ) Copyright © 2017 Elsevier Ltd Terms and Conditions
4
Fig. 3 Recommendation for a VFR family with limited budget returning to their country of origin in West Africa for a 2-month trip. P = Atovaquone/proguanil; D = Doxycycline; M = Mefloquine; None. Travel Medicine and Infectious Disease DOI: ( /j.tmaid ) Copyright © 2017 Elsevier Ltd Terms and Conditions
5
Fig. 4 Recommendation for an adult traveller with liver cirrhosis due to HCV visiting malaria-endemic areas of Sub-Saharan Africa. P = Atovaquone/proguanil; D = Doxycycline; M = Mefloquine; None. Travel Medicine and Infectious Disease DOI: ( /j.tmaid ) Copyright © 2017 Elsevier Ltd Terms and Conditions
6
Fig. 5 Recommendation for an adult traveller with renal impairment (GFR < 30 ml/min) visiting malaria-endemic areas of Sub-Saharan Africa. P = Atovaquone/proguanil; D = Doxycycline; M = Mefloquine; None. Travel Medicine and Infectious Disease DOI: ( /j.tmaid ) Copyright © 2017 Elsevier Ltd Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.